THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 118 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 7.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $160,838 | -7.9% | 18,637 | +10.5% | 0.00% | – |
Q2 2023 | $174,636 | -7.7% | 16,873 | -3.3% | 0.00% | – |
Q1 2023 | $189,256 | -9.1% | 17,443 | -6.0% | 0.00% | – |
Q4 2022 | $208,187 | +15.7% | 18,555 | +4.7% | 0.00% | – |
Q3 2022 | $180,000 | +12.5% | 17,726 | +0.3% | 0.00% | – |
Q2 2022 | $160,000 | +58.4% | 17,674 | +67.9% | 0.00% | – |
Q1 2022 | $101,000 | -45.1% | 10,525 | -57.6% | 0.00% | – |
Q3 2021 | $184,000 | -14.8% | 24,799 | +67.0% | 0.00% | – |
Q2 2021 | $216,000 | -25.0% | 14,850 | +5.2% | 0.00% | – |
Q1 2021 | $288,000 | -31.8% | 14,110 | -40.7% | 0.00% | – |
Q4 2020 | $422,000 | +146.8% | 23,776 | +105.8% | 0.00% | – |
Q3 2020 | $171,000 | -32.9% | 11,554 | -4.7% | 0.00% | – |
Q2 2020 | $255,000 | +27.5% | 12,126 | +40.3% | 0.00% | – |
Q1 2020 | $200,000 | -6.5% | 8,640 | +4.5% | 0.00% | – |
Q4 2019 | $214,000 | +5.9% | 8,267 | +4.6% | 0.00% | – |
Q4 2018 | $202,000 | -57.7% | 7,907 | -46.0% | 0.00% | – |
Q3 2018 | $478,000 | +103.4% | 14,632 | +51.3% | 0.00% | – |
Q1 2018 | $235,000 | -4.5% | 9,674 | +9.9% | 0.00% | – |
Q4 2017 | $246,000 | -16.3% | 8,806 | +2.7% | 0.00% | – |
Q3 2017 | $294,000 | -48.5% | 8,572 | -40.2% | 0.00% | -100.0% |
Q2 2017 | $571,000 | +36.0% | 14,329 | +25.7% | 0.00% | 0.0% |
Q1 2017 | $420,000 | – | 11,398 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
King Wealth Management Group | 22,500 | $583,000 | 0.15% |
Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |